메뉴 건너뛰기
Blood
Volumn 122, Issue 15, 2013, Pages 2529-2531
Two targets for the price of one
Author keywords

[No Author keywords available]
Indexed keywords

IBRUTINIB; INTERLEUKIN 2;
EID: 84888249261     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-08-518548     Document Type: Short Survey
Times cited : (6)
References (10)
  • 1
    • 84888216911 scopus 로고    scopus 로고
    • Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T-lymphocytes
    • Dubovsky JA, Beckwith KA, Natarajan G, et al. Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T-lymphocytes. Blood. 2013;122(15):2539-2549.
    • (2013) Blood , vol.122 , Issue.15 , pp. 2539-2549
    • Dubovsky, J.A.1    Beckwith, K.A.2    Natarajan, G.3
  • 2
    • 84866152172 scopus 로고    scopus 로고
    • Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
    • Dühren-von Minden M, Übelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489(7415):309-312.
    • (2012) Nature , vol.489 , Issue.7415 , pp. 309-312
    • Dühren-von Minden, M.1    Übelhart, R.2    Schneider, D.3
  • 3
    • 73849145729 scopus 로고    scopus 로고
    • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
    • Davis RE, Ngo VN, Lenz G, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010;463(7277):88-92.
    • (2010) Nature , vol.463 , Issue.7277 , pp. 88-92
    • Davis, R.E.1    Ngo, V.N.2    Lenz, G.3
  • 4
    • 84871806385 scopus 로고    scopus 로고
    • Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies
    • Advani RH, Buggy JJ, Sharman JP, et al. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies. J Clin Oncol. 2013;31(1):88-94.
    • (2013) J Clin Oncol. , vol.31 , Issue.1 , pp. 88-94
    • Advani, R.H.1    Buggy, J.J.2    Sharman, J.P.3
  • 5
    • 84879748062 scopus 로고    scopus 로고
    • Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
    • Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369(1):32-42.
    • (2013) N Engl J Med. , vol.369 , Issue.1 , pp. 32-42
    • Byrd, J.C.1    Furman, R.R.2    Coutre, S.E.3
  • 6
    • 79960133279 scopus 로고    scopus 로고
    • The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
    • Chang BY, Huang MM, Francesco M, et al. The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells. Arthritis Res Ther. 2011;13(4):R115.
    • (2011) Arthritis Res Ther. , vol.13 , Issue.4
    • Chang, B.Y.1    Huang, M.M.2    Francesco, M.3
  • 7
    • 84865585752 scopus 로고    scopus 로고
    • Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
    • Tai YT, Chang BY, Kong SY, et al. Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma. Blood. 2012;120(9):1877-1887.
    • (2012) Blood , vol.120 , Issue.9 , pp. 1877-1887
    • Tai, Y.T.1    Chang, B.Y.2    Kong, S.Y.3
  • 8
    • 79952712968 scopus 로고    scopus 로고
    • Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
    • Haabeth OA, Lorvik KB, Hammarström C, et al. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun. 2011;2:240.
    • (2011) Nat Commun. , vol.2 , pp. 240
    • Haabeth, O.A.1    Lorvik, K.B.2    Hammarström, C.3
  • 9
    • 0036242830 scopus 로고    scopus 로고
    • T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia-the three-color flow cytometry analysis
    • Podhorecka M, Dmoszynska A, Rolinski J, Wasik E. T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia-the three-color flow cytometry analysis. Leuk Res. 2002;26(7):657-660.
    • (2002) Leuk Res. , vol.26 , Issue.7 , pp. 657-660
    • Podhorecka, M.1    Dmoszynska, A.2    Rolinski, J.3    Wasik, E.4
  • 10
    • 34249000978 scopus 로고    scopus 로고
    • Lymphomas can develop from B cells chronically helped by idiotype-specific T cells
    • Zangani MM, Frøyland M, Qiu GY, et al. Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med. 2007;204(5):1181-1191.
    • (2007) J Exp Med. , vol.204 , Issue.5 , pp. 1181-1191
    • Zangani, M.M.1    Frøyland, M.2    Qiu, G.Y.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.